| 2026/02/26 | 17:14:27 | Medeon Board of Directors approved the 2025 consolidated financial reports | |
| SEQ_NO |
1 |
Date of announcement |
2026/02/26 |
Time of announcement |
17:14:27 |
| Subject |
Medeon Board of Directors approved the 2025 consolidated financial reports |
| Date of events |
2026/02/26
|
To which item it meets |
paragraph 31 |
| Statement |
1.Date of the board of directors submitted or approved:2026/02/26
2.Date of the audit committee approved:2026/02/26
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2025/01/01~2025/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):419,425
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):58,825
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):(722,514)
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):(719,693)
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):(719,341)
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):(668,062)
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):(7.24)
11.Total assets end of the period (thousand NTD):1,779,793
12.Total liabilities end of the period
(thousand NTD):243,027
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,475,740
14.Any other matters that need to be specified:None |
|
| 2026/02/25 | 16:09:37 | BOD of Medeon’s major subsidiary PMC resolved to convene the 2026 Annual Shareholders’ meeting | |
| SEQ_NO |
4 |
Date of announcement |
2026/02/25 |
Time of announcement |
16:09:37 |
| Subject |
BOD of Medeon’s major subsidiary PMC resolved to convene the 2026 Annual Shareholders’ meeting |
| Date of events |
2026/02/25
|
To which item it meets |
paragraph 17 |
| Statement |
1.Date of the board of directors resolution:2026/02/25
2.General shareholders’ meeting date:2026/05/29
3.General shareholders’ meeting location: Online Teams Meeting.
4.Cause for convening the meeting I.Reported matters:
(1) 2025 Business Report
(2) 2025 Supervisor’s Review Report
5.Cause for convening the meeting II.Acknowledged matters:
(1) 2025 Business Report and Financial Statements
(2) 2025 deficit offset proposal
6.Cause for convening the meeting III, Matters for Discussion:NA
7.Cause for convening the meeting IV.Election matters:NA
8.Cause for convening the meeting V.Other Proposals:NA
9.Cause for convening the meeting VI.Extemporary Motions:NA
10.Book closure starting date:2026/04/30
11.Book closure ending date:2026/05/29
12.Any other matters that need to be specified:NA |
|
| 2026/02/25 | 15:53:31 | BOD of Medeon’s major subsidiary PMC resolved not to distribute dividends | |
| SEQ_NO |
3 |
Date of announcement |
2026/02/25 |
Time of announcement |
15:53:31 |
| Subject |
BOD of Medeon’s major subsidiary PMC resolved not to distribute dividends |
| Date of events |
2026/02/25
|
To which item it meets |
paragraph 14 |
| Statement |
1.Date of the board of directors resolution:2026/02/25
2.Type and monetary amount of dividend distribution:not to distribute.
3.Any other matters that need to be specified:None. |
|
| 2026/02/25 | 15:45:15 | BOD of Medeon’s major subsidiary Medeologix Corporation resolved to convene the 2026 Annual Shareholders’ meeting | |
| SEQ_NO |
2 |
Date of announcement |
2026/02/25 |
Time of announcement |
15:45:15 |
| Subject |
BOD of Medeon’s major subsidiary Medeologix Corporation resolved to convene the 2026 Annual Shareholders’ meeting |
| Date of events |
2026/02/25
|
To which item it meets |
paragraph 17 |
| Statement |
1.Date of the board of directors resolution:2026/02/25
2.General shareholders’ meeting date:2026/05/29
3.General shareholders’ meeting location:Online Teams Meeting.
4.Cause for convening the meeting I.Reported matters:
(1) 2025 Business Report
(2) 2025 Supervisor’s Review Report
5.Cause for convening the meeting II.Acknowledged matters:
(1) 2025 Business Report and Financial Statements
(2) 2025 deficit offset proposal
6.Cause for convening the meeting III, Matters for Discussion:NA
7.Cause for convening the meeting IV.Election matters:NA
8.Cause for convening the meeting V.Other Proposals:NA
9.Cause for convening the meeting VI.Extemporary Motions:NA
10.Book closure starting date:2026/04/30
11.Book closure ending date:2026/05/29
12.Any other matters that need to be specified:NA |
|
| 2026/02/25 | 15:29:09 | BOD of Medeon’s major subsidiary Medeologix Corporation resolved not to distribute dividends | |
| SEQ_NO |
1 |
Date of announcement |
2026/02/25 |
Time of announcement |
15:29:09 |
| Subject |
BOD of Medeon’s major subsidiary Medeologix Corporation resolved not to distribute dividends |
| Date of events |
2026/02/25
|
To which item it meets |
paragraph 14 |
| Statement |
1.Date of the board of directors resolution:2026/02/25
2.Type and monetary amount of dividend distribution:not to distribute.
3.Any other matters that need to be specified:None. |
|
| 2026/02/13 | 16:19:36 | Announcement of the Board of Directors Meeting Date for Approval of the Fourth-Quarter 2025 Financial Report | |
| SEQ_NO |
1 |
Date of announcement |
2026/02/13 |
Time of announcement |
16:19:36 |
| Subject |
Announcement of the Board of Directors Meeting Date for Approval of the Fourth-Quarter 2025 Financial Report |
| Date of events |
2026/02/13
|
To which item it meets |
paragraph 31 |
| Statement |
1.Date of a notice of the board of directors meeting is issued:2026/02/13
2.Expected date of the board of directors meeting is convened:2026/02/26
3.Expected year and quarter of the financial reports
or the annual self-assessed financial information
submitted to the board of directors or approved by
the board of directors: Fourth-Quarter 2025
4.Any other matters that need to be specified:None |
|
| 2026/01/23 | 15:29:12 | Announcement for the issuance of new shares for cash capital increase on behalf of Medeon’s major subsidiary, AMI | |
| SEQ_NO |
2 |
Date of announcement |
2026/01/23 |
Time of announcement |
15:29:12 |
| Subject |
Announcement for the issuance of new shares for cash capital increase on behalf of Medeon’s major subsidiary, AMI |
| Date of events |
2026/01/23
|
To which item it meets |
paragraph 11 |
| Statement |
1.Date of the board of directors resolution:2026/01/23
2.Source of capital increase funds:
Issuance of preferred stocks for cash capital increase
3.Whether to adopt shelf registration
(Yes, please state issuance period/No):No
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):
Total monetary value of the issuance?GUS$2,755,000
Number of shares issued?G950,000 shares
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:N/A
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:N/A
7.Par value per share:US$0.0001
8.Issue price:US$2.9
9.Number of shares subscribed for by or allocated to employees:N/A
10.Number of shares publicly sold:N/A
11.Ratio of shares subscribed by or allotted as stock
dividends to existing shareholders:100%
12.Handling method for fractional shares and shares
unsubscripted for by the deadline:N/A
13.Rights and obligations of these newly issued shares:
The rights and obligations of the newly issued shares from this cash capital
increase are the same as those of existing preferred shares.
14.Utilization of the funds from the capital increase:
Program development requirements
15.Any other matters that need to be specified:None |
|
| 2026/01/23 | 15:24:11 | Announcement for the issuance of new shares for cash capital increase on behalf of Medeon’s major subsidiary, Medeon International, Inc. | |
| SEQ_NO |
1 |
Date of announcement |
2026/01/23 |
Time of announcement |
15:24:11 |
| Subject |
Announcement for the issuance of new shares for cash capital increase on behalf of Medeon’s major subsidiary, Medeon International, Inc. |
| Date of events |
2026/01/23
|
To which item it meets |
paragraph 11 |
| Statement |
1.Date of the board of directors resolution:2026/01/23
2.Source of capital increase funds:
Issuance of common shares for cash capital increase
3.Whether to adopt shelf registration
(Yes, please state issuance period/No):No
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):
Total monetary value of the issuance?GUS$2,755,000
Number of shares issued?GUS$2,755,000 shares
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:N/A
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:N/A
7.Par value per share:US$1
8.Issue price:US$1
9.Number of shares subscribed for by or allocated to employees:N/A
10.Number of shares publicly sold:N/A
11.Ratio of shares subscribed by or allotted as stock
dividends to existing shareholders:100%
12.Handling method for fractional shares and shares
unsubscripted for by the deadline:N/A
13.Rights and obligations of these newly issued shares:
The rights and obligations of the newly issued shares from this
cash capital increase are the same as those of existing shares.
14.Utilization of the funds from the capital increase:
To invest in subsidiary
15.Any other matters that need to be specified:None |
|
